HomeARQT • NASDAQ
add
Arcutis Biotherapeutics Inc
Previous close
$10.24
Day range
$10.05 - $10.37
Year range
$1.76 - $13.17
Market cap
1.19B USD
Avg Volume
2.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 44.76M | 17.44% |
Operating expense | 78.32M | 6.08% |
Net income | -41.54M | 7.21% |
Net profit margin | -92.81 | 20.99% |
Earnings per share | -0.33 | 54.79% |
EBITDA | -37.63M | -3.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 330.56M | 45.55% |
Total assets | 437.35M | 49.29% |
Total liabilities | 280.71M | 14.00% |
Total equity | 156.64M | — |
Shares outstanding | 117.04M | — |
Price to book | 7.64 | — |
Return on assets | -22.14% | — |
Return on capital | -25.74% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -41.54M | 7.21% |
Cash from operations | -34.69M | 21.13% |
Cash from investing | 84.78M | 86.12% |
Cash from financing | 394.00K | -54.56% |
Net change in cash | 50.58M | 2,045.99% |
Free cash flow | -16.51M | 37.69% |
About
Founded
2016
Headquarters
Website
Employees
296
